Nanohale AG (FYB) | WebDisclosure

Basculer en Français

8295	Companies
114810	Keywords
55260	Articles
62423	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 11/19/2024 at 06:35, 2 days 3 hours ago

Formycon annonce une conférence téléphonique sur les résultats financiers et une participation à la conférence

Résultats Financiers Formycon AG Bourse De Francfort Conférence Des Investisseurs Conférence Téléphonique Sur Les Résultats Financiers
BRIEF

published on 11/19/2024 at 06:35, 2 days 3 hours ago

Formycon Announces Earnings Call and Conference Participation

Financial Results Investor Conference Frankfurt Stock Exchange Formycon AG Earnings Call
PRESS RELEASE

published on 11/19/2024 at 06:30, 2 days 3 hours ago

Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences
Formycon AG invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences. Management Board to discuss key financial figures and recent uplisting to the Prime Standard of Frankfurt Stock Exchange

Investor Conferences Formycon AG Biosimilars Earnings Call Nine-month Results
BRIEF

published on 11/18/2024 at 06:35, 3 days 3 hours ago

Le biosimilaire FYB203 de Formycon reçoit un avis positif du CHMP

Formycon AG Biosimilaire FYB203 Approbation Du CHMP Aflibercept
BRIEF

published on 11/18/2024 at 06:35, 3 days 3 hours ago

Formycon's FYB203 Biosimilar Receives Positive CHMP Opinion

Formycon AG Biosimilar FYB203 CHMP Approval Aflibercept
PRESS RELEASE

published on 11/18/2024 at 06:30, 3 days 3 hours ago

Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama®
Formycon receives positive CHMP opinion for FYB203, a biosimilar candidate to Eylea, under tradenames AHZANTIVE and Baiama. Approval decision by European Commission expected in January 2025

Formycon Eylea CHMP Opinion Biosimilar Candidate AHZANTIVE
BRIEF

published on 11/15/2024 at 18:23, 5 days 15 hours ago

Positive CHMP Opinion for Formycon's Aflibercept-Biosimilar FYB203

Formycon AG FYB203 CHMP Opinion EMA Approval Biosimilar Drug
BRIEF

published on 11/15/2024 at 18:23, 5 days 15 hours ago

Avis positif du CHMP pour le biosimilaire Aflibercept FYB203 de Formycon

Formycon AG FYB203 Avis Du CHMP Approbation De L'EMA Médicament Biosimilaire
PRESS RELEASE

published on 11/15/2024 at 18:18, 5 days 15 hours ago

EQS-Adhoc: Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA
Formycon AG announces positive CHMP opinion from EMA for Aflibercept-Biosimilar FYB203 (AHZANTIVE®/ Baiama®) as a treatment for retinal diseases. Market approval expected by January 2025

Formycon AG EMA Retinal Diseases CHMP Opinion Aflibercept-Biosimilar FYB203
BRIEF

published on 11/11/2024 at 17:46, 9 days 16 hours ago

Formycon AG Extends CEO Contract and Joins Prime Standard

Frankfurt Stock Exchange Formycon AG Biosimilars Prime Standard Stefan Glombitza

Accesswire

Published on 11/21/2024 at 09:00, 1 hour 1 minute ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 26 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 36 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 10 hours 1 minute ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 11 hours 1 minute ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 19 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 59 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 1 hour 1 minute ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 1 hour 1 minute ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 45 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 3 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours 3 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours 3 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 53 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 41 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE